Local and global resting state activity in the noradrenergic and dopaminergic pathway modulated by reboxetine and amisulpride in healthy subjects

International Journal of Neuropsychopharmacology

Volumn 19, Issue 2, 2016, Pages

  Metzger, Coraline D ^a,c,d   Wiegers, Maike ^b   Walter, Martin ^a,c   Abler, Birgit ^b   Graf, Heiko ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Amisulpride; Dopamine; Noradrenaline; Pharmacological resting state fMRI; Reboxetine

Indexed keywords

AMISULPRIDE; DOPAMINE; NORADRENALIN; REBOXETINE; ADRENERGIC RECEPTOR AFFECTING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; MORPHOLINE DERIVATIVE; SULPIRIDE; SULTOPRIDE;

ADULT; AMYGDALA; ARTICLE; BEHAVIOR; BRAIN FUNCTION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPAMINERGIC SYSTEM; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LOCUS CERULEUS; MALE; NORADRENERGIC SYSTEM; NORMAL HUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PUTAMEN; RANDOMIZED CONTROLLED TRIAL; RESTING STATE NETWORK; SUBSTANTIA NIGRA; TECTUM; THALAMUS; ADRENERGIC NERVE CELL; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; METABOLISM; NERVE TRACT; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; YOUNG ADULT;

ADRENERGIC NEURONS; ADRENERGIC UPTAKE INHIBITORS; ADULT; ANIMALS; BRAIN; CROSS-OVER STUDIES; DOPAMINE ANTAGONISTS; DOPAMINERGIC NEURONS; DOUBLE-BLIND METHOD; HEALTHY VOLUNTEERS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MORPHOLINES; NEURAL PATHWAYS; SULPIRIDE; YOUNG ADULT;

EID: 84963766143     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv080     Document Type: Article

References (77)

1. Abler B, Seeringer A, Hartmann A, Grön G, Metzger C, Walter M, Stingl J (2011) Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled FMRI study on healthy males under subchronic paroxetine and bupropion. Neuropsychopharmacology 36:1837-1847.
2. Abler B, Grön G, Hartmann A, Metzger C, Walter M (2012) Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs. J Neurosci 32:1329-1335.
3. Abler B, Kumpfmüller D, Grön G, Walter M, Stingl J, Seeringer A (2013) Neural correlates of erotic stimulation under different levels of female sexual hormones. PLOS ONE 8:e54447.
4. Anderson A, Cohen MS (2013) Decreased small-world functional network connectivity and clustering across resting state networks in schizophrenia: an fMRI classification tutorial. Front Hum Neurosci 7:520. doi: 10.3389/fnhum.2013.00520.
5. Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP (1994) Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. Am J Psych 151:681-686.
6. Berman MG, Peltier S, Nee DE, Kross E, Deldin PJ, Jonides J (2011) Depression, rumination and the default network. Soc Cogn Affect Neurosci 6:548-555.
7. Biswal B, Yetkin FZ, Haughton VM, Hyde JS (1995) Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34:537-541.
8. Brühl AB, Jäncke L, Herwig U (2011) Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants. Psychopharmacology (Berl) 216:389-399.
9. Buckner RL, Andrews-Hanna JR, Schacter DL (2008) The brain's default network: anatomy, function, and relevance to disease. Ann NY Acad Sci 1124:1-38.
10. Castellanos FX, Di Martino A, Craddock RC, Mehta AD, Milham MP (2013) Clinical applications of the functional connectome. Neuroimage 80:527-540.
11. Chandley MJ, Ordway GA (2012) Noradrenergic dysfunction in depression and suicide. In: The neurobiological basis of suicide (Dwivedi Y, ed), pp29-64. Boca Raton (FL): CRC Press; Chapter 3. Available from: http://www.ncbi.nlm.nih.gov/books/NBK107205/.
12. Chang C, Glover GH (2009) Effects of model-based physiological noise correction on default mode network anti-correlations and correlations. Neuroimage 47:1448-1459.
13. Chang C, Metzger CD, Glover GH, Duyn JH, Heinze H, Walter M (2013) Association between heart rate variability and fluctuations in resting-state functional connectivity. Neuroimage 68:93-104.
14. Chao-Gan Y, Yu-Feng Z (2010) DPARSF: a MATLAB toolbox for "pipeline" data analysis of resting-state fMRI. Front Syst Neurosci 4:13. doi:10.3389/fnsys.2010.00013.
15. Craddock RC, Holtzheimer PE, Hu XP, Mayberg HS (2009) Disease state prediction from resting state functional connectivity. Magn Reson Med 62:1619-1628.
16. Cudennec A, Fage D, Bénavidès J, Scatton B (1997) Effects of amisulpride, an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors, on integrated functional cerebral activity in the rat. Brain Res 768:257-265.
17. Cullen KR, Gee DG, Klimes-Dougan B, Gabbay V, Hulvershorn L, Mueller BA, Camchong J, Bell CJ, Houri A, Kumra S, Lim KO, Castellanos FX, Milham MP (2009) A preliminary study of functional connectivity in comorbid adolescent depression. Neurosci Lett 460:227-231.
18. Delgado PL, Moreno FA (2000) Role of norepinephrine in depression. J Clin Psychiatry 61(Supp 1):5-12.
19. Dodds CM, Clark L, Dove A, Regenthal R, Baumann F, Bullmore E, Robbins TW, Müller U (2009) The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory. Psychopharmacology (Berl) 207:35-45.
20. Dunlop BW, Nemeroff CB (2007) The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64:327-337.
21. Fitzgerald PJ (2014) Is elevated norepinephrine an etiological factor in some cases of schizophrenia? Psychiatry Res.
22. Glover GH, Li TQ, Ress D (2000) Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR. Magn Reson Med 44:162-167.
23. Graf H, Abler B, Hartmann A, Metzger CD, Walter M (2013) Modulation of attention network activation under antidepressant agents in healthy subjects. Int J Neuropsychop 16:1219-1230.
24. Graf H, Wiegers M, Metzger CD, Walter M, Grön G, Abler B (2015) Erotic Stimulus Processing under Amisulpride and Reboxetine: A Placebo-Controlled fMRI Study in Healthy Subjects. Int J Neuropsychop 18: 1-8. doi:10.1093/ijnp/pyu004.
25. Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H, Reiss AL, Schatzberg AF (2007) Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 62:429-437.
26. Hadley JA, Nenert R, Kraguljac NV, Bolding MS, White DM, Skidmore FM, Visscher KM, Lahti AC (2014) Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia. Neuropsychopharmacology 39:1020-1030.
27. Hajós M, Fleishaker JC, Filipiak-Reisner JK, Brown MT, Wong EHF (2004) The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. CNS Drug Rev 10:23-44.
28. Hamilton JP, Furman DJ, Chang C, Thomason ME, Dennis E, Gotlib IH (2011) Default-mode and task-positive network activity in major depressive disorder: implications for adaptive and maladaptive rumination. Biol Psychiatry 70:327-333.
29. Hautzinger M, Bailer M (1993) ADS, Allgemeine Depressions-Skala Manual. Weinheim, Germany: Beltz.
30. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA (1996) Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psych 153:41-49.
31. Horn DI, Yu C, Steiner J, Buchmann J, Kaufmann J, Osoba A, Eckert U, Zierhut KC, Schiltz K, He H, Biswal B, Bogerts B, Walter M (2010) Glutamatergic and resting-state functional connectivity correlates of severity in major depression-the role of pregenual anterior cingulate cortex and anterior insula. Front Syst Neurosci 4:33. doi: 10.3389/fnsys.2010.00033.
32. Invernizzi RW, Garattini S (2004) Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog Neuropsychopharmacol Biol Psychiatry 28:819-827.
33. Invernizzi RW, Parini S, Sacchetti G, Fracasso C, Caccia S, Annoni K, Samanin R (2001) Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex. Br J Pharmacol 132:183-188.
34. Jacobs HI, Radua J, Lückmann HC, Sack AT (2013) Meta-analysis of functional network alterations in Alzheimer's disease: toward a network biomarker. Neurosci Biobehav Rev 37:753-765.
35. Keren NI, Lozar CT, Harris KC, Morgan PS, Eckert MA (2009) In vivo mapping of the human locus coeruleus. NeuroImage 47:1261-1267. doi:10.1016/j.neuroimage.2009.06.012.
36. Kriegeskorte N, Simmons WK, Bellgowan PSF, Baker CI (2009) Circular analysis in systems neuroscience: the dangers of double dipping. Nat Neurosci 12:535-540.
37. Kriegeskorte N, Lindquist MA, Nichols TE, Poldrack RA, Vul E (2010) Everything you never wanted to know about circular analysis, but were afraid to ask. J Cereb Blood Flow Metab 30:1551-1557.
38. Kuepper R, Skinbjerg M, Abi-Dargham A (2012) The dopamine dysfunction in schizophrenia revisited: new insights into topography and course. Handb Exp Pharmacol:1-26. doi:10.1007/978-3-642-25761-2-1.
39. Kukolja J, Klingmüller D, Maier W, Fink GR, Hurlemann R (2011) Noradrenergic-glucocorticoid modulation of emotional memory encoding in the human hippocampus. Psychol Med 41:2167-2176.
40. La Fougère C, Meisenzahl E, Schmitt G, Stauss J, Frodl T, Tatsch K, Hahn K, Möller H, Dresel S (2005) D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. J Nucl Med 46:1028-1033.
41. Lau C, Wang H, Hsu J, Liu M (2013) Does the dopamine hypothesis explain schizophrenia? Rev Neurosci 24:389-400. doi: 10.1515/revneuro-2013-0011.
42. Logan J, Wang G, Telang F, Fowler JS, Alexoff D, Zabroski J, Jayne M, Hubbard B, King P, Carter P, Shea C, Xu Y, Muench L, Schlyer D, Learned-Coughlin S, Cosson V, Volkow ND, Ding Y (2007) Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress. Nucl Med Biol 34:667-679.
43. Lord A, Horn D, Breakspear M, Walter M, Zang Y (2012) Changes in community structure of resting state functional connectivity in unipolar depression. PLOS ONE 7:e41282.
44. McCabe C, Mishor Z (2011) Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers. Neuroimage 57:1317-1323.
45. Mehta MA, McGowan SW, Lawrence AD, Aitken MRF, Montgomery AJ, Grasby PM (2003) Systemic sulpiride modulates striatal blood flow: relationships to spatial working memory and planning. Neuroimage 20:1982-1994.
46. Metzger CD, Eckert U, Steiner J, Sartorius A, Buchmann JE, Stadler J, Tempelmann C, Speck O, Bogerts B, Abler B, Walter M (2010) High field FMRI reveals thalamocortical integration of segregated cognitive and emotional processing in mediodorsal and intralaminar thalamic nuclei. Front Neuroanat 4:138. doi: 10.3389/fnana.2010.00138.
47. Metzger CD, van der Werf YD, Walter M (2013a) Functional mapping of thalamic nuclei and their integration into cortico-striatal-thalamo-cortical loops via ultra-high resolution imaging-from animal anatomy to in vivo imaging in humans. Front Neurosci 7:24. doi:10.3389/fnins.2013.00024.
48. Metzger CD, Walter M, Graf H, Abler B (2013b) SSRI-related modulation of sexual functioning is predicted by pre-treatment resting state functional connectivity in healthy men. Arch Sex Behav 42:935-947.
49. Montgomery SA (2002) Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders. Int Clin Psychopharmacol 17(Supp 4):S9-15; discussion S16-7.
50. Nielsen JA, Zielinski BA, Fletcher PT, Alexander AL, Lange N, Bigler ED, Lainhart JE, Anderson JS (2013) Multisite functional connectivity MRI classification of autism: ABIDE results. Front Hum Neurosci 7:599. doi:10.3389/fnhum.2013.00599.
51. Nielsen MO, Rostrup E, Wulff S, Bak N, Broberg BV, Lublin H, Kapur S, Glenthoj B (2012) Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. Arch Gen Psychiatry 69:1195-1204.
52. Nieuwenhuys R, Voogd J, van Huijzen C (2008) The human central nervous system. Berlin, Germany: Springer.
53. Onur OA, Walter H, Schlaepfer TE, Rehme AK, Schmidt C, Keysers C, Maier W, Hurlemann R (2009) Noradrenergic enhancement of amygdala responses to fear. Soc Cogn Affect Neurosci 4:119-126.
54. Ortega JE, Fernández-Pastor B, Callado LF, Meana JJ (2010) In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism. Eur Neuropsychopharmacol 20:813-822.
55. Page ME (2003) The promises and pitfalls of reboxetine. CNS Drug Rev 9:327-342.
56. Page ME, Lucki I (2002) Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex. Neuropsychopharmacology 27:237-247.
57. Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B (1997) Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. J Pharm Exp Ther 280:73-82.
58. Posner J, Park C, Wang Z (2014) Connecting the dots: a review of resting connectivity MRI studies in attention-deficit/hyperactivity disorder. Neuropsychol Rev. 24:3-15.
59. Price JL, Drevets WC (2012) Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci 16:61-71.
60. Racagni G, Canonico PL, Ravizza L, Pani L, Amore M (2004) Consensus on the use of substituted benzamides in psychiatric patients. Neuropsychobiology 50:134-143.
61. Radloff LS (1977) The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1:385-401.
62. Savitz JB, Drevets WC (2013) Neuroreceptor imaging in depression. Neurobiol Dis 52:49-65.
63. Scatton B, Claustre Y, Cudennec A, Oblin A, Perrault G, Sanger DJ, Schoemaker H (1997) Amisulpride: from animal pharmacology to therapeutic action. Int Clin Psychopharmacol 12(Supp 2):S29-36.
64. Schildkraut JJ, Kety SS (1967) Biogenic amines and emotion. Science 156:21-37.
65. Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B (1997) Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J Pharm Exp Ther 280:83-97.
66. Schölvinck ML, Maier A, Ye FQ, Duyn JH, Leopold DA (2010) Neural basis of global resting-state fMRI activity. Proc Natl Acad Sci USA 107:10238-10243.
67. Sekar S, van Audekerke J, Vanhoutte G, Lowe AS, Blamire AM, van der Linden A, Steckler T, Shoaib M, Verhoye M (2011) Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging. Psychopharmacology (Berl) 217:549-557.
68. Sheline YI, Raichle ME (2013) Resting state functional connectivity in preclinical Alzheimer's disease. Biol Psychiatry 74:340-347.
69. Smeraldi E (1998) Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study. J Affect Disord 48:47-56.
70. Song X, Dong Z, Long X, Li S, Zuo X, Zhu C, He Y, Yan C, Zang Y (2011) REST: a toolkit for resting-state functional magnetic resonance imaging data processing. PLOS ONE 6:e25031.
71. Szabadi E (2013) Functional neuroanatomy of the central noradrenergic system. J Psychopharmacol 27:659-693.
72. van Tol MJ, Li M, Metzger CD, Hailla N, Horn DI, Li W, Heinze HJ, Bogerts B, Steiner J, He H, Walter M (2014) Local cortical thinning links to resting-state disconnectivity in major depressive disorder. Psychol Med 44:2053-2065. doi:10.1017/S0033291713002742.
73. Vernaleken I, Siessmeier T, Buchholz H, Härtter S, Hiemke C, Stoeter P, Rösch F, Bartenstein P, Gründer G (2004) High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia. Int J Neuropsychop 7:421-430.
74. Viviani R, Graf H, Wiegers M, Abler B (2013) Effects of amisulpride on human resting cerebral perfusion. Psychopharmacology (Berl) 229:95-103.
75. Vytlacil J, Kayser A, Miyakawa A, D'Esposito M (2014) An approach for identifying brainstem dopaminergic pathways using resting state functional MRI. PLOS ONE 9:e87109.
76. Whitfield-Gabrieli S, Ford JM (2012) Default Mode Network Activity and Connectivity in Psychopathology. Annu Rev Clin Psychol 8:49-76.
77. Zou Q, Zhu C, Yang Y, Zuo X, Long X, Cao Q, Wang Y, Zang Y (2008) An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: fractional ALFF. J Neurosci Methods 172:137-141.